A 24-week study to assess blood pressure independent effects of valsartan treatment, benazepril treatment and combination of both valsartan and benazepril treatment on urinary albumin excretion rate with type II diabetes mellitus and microalbuminuria
Phase of Trial: Phase IV
Latest Information Update: 16 Dec 2008
At a glance
- Drugs Benazepril; Valsartan
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 16 Dec 2008 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.